181 related articles for article (PubMed ID: 1457588)
1. Iron stores and serum transferrin receptor levels during recombinant human erythropoietin treatment of anemia in rheumatoid arthritis.
Vreugdenhil G; Manger B; Nieuwenhuizen C; Feelders RA; van Eijk HG; Swaak AJ
Ann Hematol; 1992 Dec; 65(6):265-8. PubMed ID: 1457588
[TBL] [Abstract][Full Text] [Related]
2. Erythroblast iron metabolism and serum soluble transferrin receptor values in the anemia of rheumatoid arthritis.
Fitzsimons EJ; Houston T; Munro R; Sturrock RD; Speekenbrink AB; Brock JH
Arthritis Rheum; 2002 Apr; 47(2):166-71. PubMed ID: 11954010
[TBL] [Abstract][Full Text] [Related]
3. Impaired erythropoietin responsiveness to the anaemia in rheumatoid arthritis. A possible inverse relationship with iron stores and effects of the oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
Vreugdenhil G; Kontoghiorghes GJ; Van Eijk HG; Swaak AJ
Clin Exp Rheumatol; 1991; 9(1):35-40. PubMed ID: 2054965
[TBL] [Abstract][Full Text] [Related]
4. Suppressed serum erythropoietin response to anemia and the efficacy of recombinant erythropoietin in the anemia of rheumatoid arthritis.
Takashina N; Kondo H; Kashiwazaki S
J Rheumatol; 1990 Jul; 17(7):885-7. PubMed ID: 2213753
[TBL] [Abstract][Full Text] [Related]
5. Correction of iron-deficient erythropoiesis in the treatment of anemia of chronic disease with recombinant human erythropoietin.
Arndt U; Kaltwasser JP; Gottschalk R; Hoelzer D; Möller B
Ann Hematol; 2005 Mar; 84(3):159-66. PubMed ID: 15565327
[TBL] [Abstract][Full Text] [Related]
6. Markers of masked iron deficiency and effectiveness of EPO therapy in chronic renal failure.
Ahluwalia N; Skikne BS; Savin V; Chonko A
Am J Kidney Dis; 1997 Oct; 30(4):532-41. PubMed ID: 9328369
[TBL] [Abstract][Full Text] [Related]
7. Circulating transferrin receptor during erythropoietin medication of anemic patients with rheumatoid arthritis.
Pettersson T; Teppo AM; Siimes MA
Scand J Rheumatol; 1996; 25(5):321-4. PubMed ID: 8921926
[TBL] [Abstract][Full Text] [Related]
8. Single values of serum transferrin receptor and transferrin receptor ferritin index can be used to detect true and functional iron deficiency in rheumatoid arthritis patients with anemia.
Suominen P; Möttönen T; Rajamäki A; Irjala K
Arthritis Rheum; 2000 May; 43(5):1016-20. PubMed ID: 10817554
[TBL] [Abstract][Full Text] [Related]
9. Soluble transferrin receptor, ferritin and soluble transferrin receptor--Ferritin index in assessment of anaemia in rhaeumatoid arthritis.
Pavai S; Jayaranee S; Sargunan S
Med J Malaysia; 2007 Oct; 62(4):303-7. PubMed ID: 18551934
[TBL] [Abstract][Full Text] [Related]
10. Anemia associated with advanced prostatic adenocarcinoma: effects of recombinant human erythropoietin.
Beshara S; Letocha H; Linde T; Wikström B; Sandhagen B; Nilsson S; Danielson BG
Prostate; 1997 May; 31(3):153-60. PubMed ID: 9167766
[TBL] [Abstract][Full Text] [Related]
11. Interactions between erythropoietin and iron metabolism in anaemia of chronic disorders.
Vreugdenhil G; Nieuwenhuizen C; Swaak AJ
Eur J Haematol; 1992 Jan; 48(1):56-7. PubMed ID: 1730281
[No Abstract] [Full Text] [Related]
12. Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis.
Cazzola M; Ponchio L; de Benedetti F; Ravelli A; Rosti V; Beguin Y; Invernizzi R; Barosi G; Martini A
Blood; 1996 Jun; 87(11):4824-30. PubMed ID: 8639855
[TBL] [Abstract][Full Text] [Related]
13. Serum soluble transferrin receptor reflects erythropoiesis but not iron availability in erythropoietin-treated chronic hemodialysis patients.
Chiang WC; Tsai TJ; Chen YM; Lin SL; Hsieh BS
Clin Nephrol; 2002 Nov; 58(5):363-9. PubMed ID: 12425487
[TBL] [Abstract][Full Text] [Related]
14. Soluble transferrin receptor and soluble transferrin receptor-ferritin index for evaluation of the iron status in elderly patients.
Genc S; Erten N; Karan MA; Besisik SK; Saka B; Tascioglu C; Sivas A
Tohoku J Exp Med; 2004 Feb; 202(2):135-42. PubMed ID: 14998307
[TBL] [Abstract][Full Text] [Related]
15. Serum transferrin receptor levels in anaemic patients with rheumatoid arthritis.
Nielsen OJ; Andersen LS; Hansen NE; Hansen TM
Scand J Clin Lab Invest; 1994 Feb; 54(1):75-82. PubMed ID: 8171275
[TBL] [Abstract][Full Text] [Related]
16. Evidence for impaired erythropoietin response to anaemia in rheumatoid disease.
Boyd HK; Lappin TR; Bell AL
Br J Rheumatol; 1991 Aug; 30(4):255-9. PubMed ID: 1863821
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anaemia of chronic disease; utility measures correlate strongly with disease activity measures.
Peeters HR; Jongen-Lavrencic M; Bakker CH; Vreugdenhil G; Breedveld FC; Swaak AJ
Rheumatol Int; 1999; 18(5-6):201-6. PubMed ID: 10399796
[TBL] [Abstract][Full Text] [Related]
18. Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial.
Peeters HR; Jongen-Lavrencic M; Vreugdenhil G; Swaak AJ
Ann Rheum Dis; 1996 Oct; 55(10):739-44. PubMed ID: 8984939
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of the anemia of rheumatoid arthritis with subcutaneously administered recombinant human erythropoietin. Slower response in patients with more severe inflammation.
Pettersson T; Rosenlöf K; Friman C; Mickos A; Teppo AM; Fyhrquist F
Scand J Rheumatol; 1993; 22(4):188-93. PubMed ID: 8356412
[TBL] [Abstract][Full Text] [Related]
20. Subcutaneous recombinant human erythropoietin for the treatment of anemia in myelodysplastic syndromes.
Ghio R; Balleari E; Ballestrero A; Gatti AM; Mareni C; Massa G; Patrone F; Sessarego M; Timitilli S
Acta Haematol; 1993; 90(2):58-64. PubMed ID: 8285019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
